1. Home
  2. CALC vs NDLS Comparison

CALC vs NDLS Comparison

Compare CALC & NDLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CalciMedica Inc.

CALC

CalciMedica Inc.

HOLD

Current Price

$0.63

Market Cap

9.7M

Sector

Health Care

ML Signal

HOLD

Logo Noodles & Company

NDLS

Noodles & Company

HOLD

Current Price

$12.33

Market Cap

68.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CALC
NDLS
Founded
2011
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
9.7M
68.7M
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
CALC
NDLS
Price
$0.63
$12.33
Analyst Decision
Buy
Hold
Analyst Count
2
1
Target Price
$10.00
N/A
AVG Volume (30 Days)
126.0K
59.2K
Earning Date
05-13-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.30
N/A
Revenue
N/A
$495,089,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$2.18
N/A
Revenue Growth
N/A
0.37
52 Week Low
$0.46
$0.47
52 Week High
$7.20
$13.95

Technical Indicators

Market Signals
Indicator
CALC
NDLS
Relative Strength Index (RSI) 47.64 62.93
Support Level $0.50 $0.60
Resistance Level $0.78 $13.95
Average True Range (ATR) 0.05 1.08
MACD 0.01 -0.12
Stochastic Oscillator 46.51 53.77

Price Performance

Historical Comparison
CALC
NDLS

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys. The company operates as one operating segment focused on developing and commercializing therapeutics in the U.S.

About NDLS Noodles & Company

Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services. It is focused on offering customers flavorful, cooked-to-order dishes in a warm and welcoming environment at an attractive value. It has approximately 340 company-owned restaurants and 83 franchise restaurants in 31 states.

Share on Social Networks: